Juggling the COVID‐19 pandemic: A cytopathology point of view,Cytopathology

当前位置： X-MOL 学术 › Cytopathology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Juggling the COVID‐19 pandemic: A cytopathology point of view
Cytopathology ( IF 1.2 ) Pub Date : 2020-11-03 , DOI: 10.1111/cyt.12936
Antonino Iaccarino ₁ , Pasquale Pisapia ₁ , Elena Vigliar ₁ , Philippe Vielh ₂ , Giancarlo Troncone ₁

Affiliation

Since its first identification in China at the end of 2019, severe acute respiratory syndrome coronavirus 2 has rapidly spread all over the world, becoming an international healthcare emergency. In the era of coronavirus disease‐2019 (COVID‐19), several aspects of normal life, including those related to the medical activities, have been radically changed. Extraordinary measures have been adopted by different nations to cope with the rapid diffusion of COVID‐19 all over the world. In hospitals, careful attention has been paid to manage infected patients with a possible detrimental effect for patients affected by other diseases. As with other medical fields, cytopathology laboratories have also drastically modified their activities to cope with the COVID‐19 healthcare emergency. Here, the main effects of COVID‐19 pandemic on the routine practice of cytopathology are summarised, focusing on the prioritisation policy adopted by cytopathologists worldwide.

更新日期：2020-11-03

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11